Developer docs
API playgroundTry for free, no card

Search company profiles

Cambridge Crossing

Full company profile

uuid000z3jh

Namestring
Cambridge Crossing
Legal namestring
DivcoWest Real Estate Services, LLC
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Cambridge Crossing (CX) is a 43-acre, 4.5-million-square-foot master-planned mixed-use development in East Cambridge, Massachusetts, at the intersection of Cambridge, Boston, and Somerville within the Kendall Square innovation district. Developed and owned by DivcoWest (a private real estate investment firm founded in 1993), CX broke ground in October 2017 and currently has approximately 1.9 million SF of completed inventory with the remainder phased for future construction. The project integrates life science and technology laboratory/office buildings, multifamily residential, ground-floor retail and restaurants, and 11 acres of public open space, all served by two on-site MBTA stations (Lechmere Green Line and Community College Orange Line).

The commercial portfolio comprises six life science and technology buildings — including 350/450 Water Street (Sanofi consolidated campus, ~900,000 SF), 250 Water Street (Bristol Myers Squibb, ~480,000 SF), 222 Jacobs Street (Philips North American HQ, AbbVie, Cerevel, ~430,000 SF), 441 Morgan Avenue (Astellas, LEED Platinum, ~375,000 SF), and 121 Morgan Avenue (~167,300 SF) — designed to LEED Gold v4 or higher standards with WiredScore and WELL certifications. The residential component is anchored by Park 151, a 468-unit mixed-income building developed in joint venture with LCOR that opened in 2022, supplemented by 14 North First Street (120 units). Retail includes The Shed (18,000 SF) and 181 Morgan Avenue (20,000 SF), housing tenants such as REI, Tatte Bakery, Bon Me, and Lamplighter Brewing, supported by curated community programming (CX Summer Series, CX Fit, CX Movie Nights, CX Cycle Fest) and amenity infrastructure including the Katherine "Kittie" Knox Cycle Center and Kith Corner early childhood education center.

Cambridge Crossing's revenue model is primarily recurring rental income from long-term commercial leases with enterprise life science and technology tenants, supplemented by residential rent at Park 151 and ground-floor retail leases. GTM is direct enterprise leasing through Mark Roopenian at DivcoWest for commercial space, Park 151 property management for residential, and Graffito SP for retail, with marketing emphasizing the transit-oriented location, sustainability credentials, and integrated live-work-play neighborhood positioning.

Short descriptiontext

Cambridge Crossing is a 43-acre, 4.5 million SF master-planned mixed-use neighborhood in East Cambridge, MA, developed by DivcoWest, offering life science/tech lab space, multifamily residential (Park 151, 468 units), retail, and 11 acres of open space served by two MBTA stations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mixed-use real estate, commercial leasing, residential leasing, life science properties, retail leasing
Industry2 codes
1Urban Planning & Master Planning
CodeBPAHAKADPrimaryYes
2Retail & Mixed-Use Commercial Construction
CodeIMAFACABPrimaryNo
NAICS code2 codes
  • New Multifamily Housing Construction (except For-Sale Builders)236116
  • Commercial and Institutional Building Construction236220
SIC code2 codes
  • Real Estate6500
  • Land Subdividers & Developers (No Cemeteries)6552
Product category
Mixed-Use Real Estate Development
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Commercial Life Science Leasing
TypeSubscription Recurring
Description

Leasing of laboratory and office space to life science, biotechnology, and technology companies. Buildings include 250 Water Street (480,000 SF), 222 Jacobs Street (430,000 SF), 350 Water Street (510,000 SF), 450 Water Street (405,000 SF), 441 Morgan Avenue (375,000 SF), and 121 Morgan Avenue (167,300 SF).

cambridgecrossing.com
2Residential Leasing
TypeSubscription Recurring
Description

Leasing of apartment units at Park 151, a 468-unit residential building with market-rate, penthouse, and affordable units.

cambridgecrossing.com
3Retail Leasing
TypeSubscription Recurring
Description

Ground-floor retail and restaurant space leasing throughout the development including The Shed (18,000 SF), 181 Morgan Ave (20,000 SF), and other retail locations.

cambridgecrossing.com
4Amenity and Event Programming
TypeSubscription Recurring
Description

Community events and programming including CX Summer Nights, CX Fit, and CX Movie Nights that drive foot traffic to retail tenants.

cambridgecrossing.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Infrastructure, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Cambridge Crossing is a 43-acre, 4.5-million-square-foot mixed-use real estate neighborhood in East Cambridge, MA, developed by DivcoWest. The development leases life science and technology commercial buildings, multifamily residential apartments (Park 151), and ground-floor retail/restaurant space to enterprise tenants and individual residents, supported by 11 acres of public open space and seasonal community programming.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • LEED Platinum certification achieved at 441 Morgan Avenue life science building, reducing potable water use by up to 100% during peak seasons
+2 more records
Product overview1 text field

Cambridge Crossing (CX) is a 43-acre, 4.5-million-square-foot mixed-use destination neighborhood and innovation hub in East Cambridge, MA, developed by DivcoWest. The portfolio comprises life science and technology commercial buildings (including 441 Morgan Avenue, 250 Water Street, 222 Jacobs Street, 350/450 Water Street, 121 Morgan Avenue), multifamily residential buildings (Park 151 with 468 units, 14 North First Street with 120 units), and ground-floor retail spaces (The Shed at 100/110 North First Street, 181 Morgan Avenue, 124-144 Morgan Avenue). CX offers 11 acres of public open spaces and hosts seasonal community programming (CX Summer Nights, CX Fit, CX Movie Nights, CX Cycle Fest). Amenities include the Katherine 'Kittie' Knox Cycle Center, the Brian P. Murphy Memorial Staircase, and the Kith Corner early childhood education center at Park 151. The neighborhood is served by two on-site MBTA stations.

Product and service12 records
1Cambridge Crossing Mixed-Use Neighborhood
CategoryMixed-Use Real Estate Development
Description

A 43-acre, 4.5-million-square-foot mixed-use innovation hub and destination neighborhood in East Cambridge, MA, combining life science and technology commercial space, residential buildings, retail and dining, and 11 acres of public open space.

2441 Morgan Avenue Life Science Building
CategoryCommercial Leasing - Life Science
Description

A 375,000 SF, 10-story plus two penthouse floors lab-ready life science building targeting LEED Platinum certification. Features five outdoor terraces, direct access to a five-acre park, integrated View Glass smart technology, three underground parking levels, a bike room with showers and lockers, and public art. Currently home to Astellas Pharma.

3250 Water Street Life Science Building
CategoryCommercial Leasing - Life Science
Description

A 480,000 SF, 9-floor life science building at Cambridge Crossing. Tenants include Bristol Myers Squibb.

4222 Jacobs Street Science and Technology Building
CategoryCommercial Leasing - Science and Technology
Description

A 430,000 SF building at Cambridge Crossing housing tenants Philips, AbbVie, Tatte Bakery, and Bon Me.

5350 Water Street Science Building
CategoryCommercial Leasing - Life Science
Description

A 510,000 SF, 12-floor building at Cambridge Crossing. Primary tenant is Sanofi.

6450 Water Street Technology Building
CategoryCommercial Leasing - Technology
Description

A 405,000 SF building at Cambridge Crossing. Tenants include Sanofi and Starbucks.

7121 Morgan Avenue Life Science Building
CategoryCommercial Leasing - Life Science
Description

A 167,300 SF, 5-floor life science building at Cambridge Crossing.

8Park 151 Multifamily Residential
CategoryResidential Leasing
Description

A 20-story, 468-unit mixed-income residential building at 151 North First Street at Cambridge Crossing, developed in partnership with LCOR. Features include an outdoor pool, fitness center, co-working spaces, indoor/outdoor yoga, sunset terrace, sports simulator, and 19,000 SF of ground-floor retail.

914 North First Street Residential Building
CategoryResidential Leasing
Description

A residential building at Cambridge Crossing with 120 units across 8 floors and 18,000 SF of ground-floor retail.

10The Shed Retail Space (100 & 110 North First Street)
CategoryRetail Leasing
Description

An 18,000 SF, two-floor retail building at Cambridge Crossing housing The Lexington, Geppetto, Café Beatrice, and Lamplighter Brewing Co.

11181 Morgan Avenue Commercial and Retail Building
CategoryRetail and Commercial Leasing
Description

A 20,000 SF commercial and retail building at Cambridge Crossing. Tenants include REI and DivcoWest.

12CX Public Open Spaces
CategoryPublic Amenities
Description

Eleven acres of public open space at Cambridge Crossing, anchored by The Common at CX (5-acre central green space), and including Maria Baldwin Courtyard, Picnic Grove, William Dawes Field, Amelia Earhart Square, Katherine 'Kittie' Knox Cycle Center, Brian P. Murphy Memorial Staircase, The Dog Run at Child Street Plaza, Lois Lilley Howe Event Plaza, and Pauline Elizabeth Hopkins Lawn.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
1LCOR
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2022-05-02
Description

Joint venture partnership between LCOR and DivcoWest for development of Park 151, the 468-unit multifamily residential building at 151 North First Street. LCOR serves as the fully integrated real estate investment, development, and management partner for the residential component.

cambridgecrossing.com
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

DivcoWest, a DivCore Capital Company, is the parent real estate investment and development firm behind Cambridge Crossing. Founded in 1993 and headquartered in San Francisco with offices in multiple cities including Cambridge.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Artists For Humanity to create the HERStory art installation celebrating six Cambridge trailblazing women. Teen artists researched and created portraits displayed at The Shed.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Art advisory partnership facilitating public art installations at Cambridge Crossing. Collaborated on Collective Ascension mural project with Community Art Center and the Green Tara 2 installation by Sneha Shrestha.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cambridge-based organization empowering local youth to use artistic voices. Collaborated with DivcoWest on the Collective Ascension mural project incorporating teen perspectives.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Partnership for CX Summer Series events including CX Summer Nights concerts, CX Movie Nights, and community programming. ECBA provides event support and community connections.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Strategic partnership to locate the new Lechmere Green Line station and Community College Orange Line station at Cambridge Crossing. DivcoWest supported Green Line Extension (GLX) completion.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major tenant occupying two floors (62,000 SF) at 441 Morgan Avenue for Discovery Accelerator incubator and Mitobridge research operations.

Strategic tierCoreTypeTechnology or Integration
Description

Architectural firm designing 441 Morgan Avenue life science building with views of the Charles River.

Strategic tierCoreTypeTechnology or Integration
Description

Engineering and consulting partner for 441 Morgan Avenue design and sustainability features including LEED Gold targeting.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with City of Cambridge for public spaces, HERStory installation at City Hall, and community development initiatives.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Montessori-inspired early childhood education center at ground level of Park151, accommodating up to 81 children ages 6 weeks to 5 years.

13Tap 151 Bar and Grill
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Tavern-style restaurant at ground level of Park 151 with approximately 6,000 SF, 233 seats, and outdoor seating expected to open 2024.

cambridgecrossing.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Bicycle advocacy organization partnering on CX Cycle Fest events and promoting cycling infrastructure at Cambridge Crossing.

15REI
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Outdoor recreation retail co-op at 181 Morgan Avenue, participating in cycling events and community programming.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Major publicly traded office and life science landlord headquartered in Boston with substantial Cambridge holdings including Kendall Square properties. Directly comparable as a Class A office/lab developer serving similar enterprise tenants in Cambridge.

TypeDirect peer
Description

Pure-play life science real estate platform owned by Blackstone, with major Cambridge presence and a portfolio of lab/office buildings serving biotech and pharma tenants. Closely comparable in product type and target customer base.

TypeDirect peer
Description

Life science real estate developer building purpose-built lab clusters in top-tier innovation markets including San Diego and Boston. Directly comparable as a developer of master-planned life science districts for pharma/biotech tenants.

TypeDirect peer
Description

Developer and operator of innovation districts and lab/office buildings typically on or adjacent to university campuses. Comparable in lab-ready building development serving university-affiliated life science tenants.

TypeDirect peer
Description

REIT specializing in mixed-use and retail-anchored developments, including Assembly Row in Somerville (adjacent to Cambridge Crossing). Comparable in mixed-use live-work-play format and Greater Boston presence.

TypeDirect peer
Description

One of the largest privately held mixed-use developers in the U.S., best known for the Boston Seaport master-planned district. Highly comparable as a master developer of mixed-use, transit-oriented neighborhoods in Greater Boston.

TypeBroad incumbent
Description

Large diversified real estate developer/operator with major mixed-use master-planned districts (e.g., Manhattan West). Comparable in master-planning scale and mixed-use live-work-play concept, but at much broader national footprint.

TypeBroad incumbent
Description

Major global real estate developer known for master-planned mixed-use districts such as Hudson Yards. Comparable in scale and mixed-use master planning approach, though Cambridge Crossing is at a smaller, more concentrated scale.

TypeDirect peer
Description

The largest pure-play life science REIT in the U.S. with a major footprint across Cambridge and other top-tier innovation clusters. Directly comparable as a developer, owner, and operator of lab-ready buildings in Cambridge/Kendall Square targeting pharmaceutical and biotech tenants.

10LCOR
TypeDirect peer
Description

Fully integrated real estate investment, development, and management firm that is the JV partner with DivcoWest on Park 151 at Cambridge Crossing. Direct peer as a multifamily developer-operator within the same project.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cambridge Crossing

Mixed-Use Real Estate Developmentcambridgecrossing.com

Cambridge Crossing is a 43-acre, 4.5 million SF master-planned mixed-use neighborhood in East Cambridge, MA, developed by DivcoWest, offering life science/tech lab space, multifamily residential (Park 151, 468 units), retail, and 11 acres of open space served by two MBTA stations.

What Cambridge Crossing does

Cambridge Crossing (CX) is a 43-acre, 4.5-million-square-foot master-planned mixed-use development in East Cambridge, Massachusetts, at the intersection of Cambridge, Boston, and Somerville within the Kendall Square innovation district. Developed and owned by DivcoWest (a private real estate investment firm founded in 1993), CX broke ground in October 2017 and currently has approximately 1.9 million SF of completed inventory with the remainder phased for future construction. The project integrates life science and technology laboratory/office buildings, multifamily residential, ground-floor retail and restaurants, and 11 acres of public open space, all served by two on-site MBTA stations (Lechmere Green Line and Community College Orange Line).

The commercial portfolio comprises six life science and technology buildings — including 350/450 Water Street (Sanofi consolidated campus, ~900,000 SF), 250 Water Street (Bristol Myers Squibb, ~480,000 SF), 222 Jacobs Street (Philips North American HQ, AbbVie, Cerevel, ~430,000 SF), 441 Morgan Avenue (Astellas, LEED Platinum, ~375,000 SF), and 121 Morgan Avenue (~167,300 SF) — designed to LEED Gold v4 or higher standards with WiredScore and WELL certifications. The residential component is anchored by Park 151, a 468-unit mixed-income building developed in joint venture with LCOR that opened in 2022, supplemented by 14 North First Street (120 units). Retail includes The Shed (18,000 SF) and 181 Morgan Avenue (20,000 SF), housing tenants such as REI, Tatte Bakery, Bon Me, and Lamplighter Brewing, supported by curated community programming (CX Summer Series, CX Fit, CX Movie Nights, CX Cycle Fest) and amenity infrastructure including the Katherine "Kittie" Knox Cycle Center and Kith Corner early childhood education center.

Cambridge Crossing's revenue model is primarily recurring rental income from long-term commercial leases with enterprise life science and technology tenants, supplemented by residential rent at Park 151 and ground-floor retail leases. GTM is direct enterprise leasing through Mark Roopenian at DivcoWest for commercial space, Park 151 property management for residential, and Graffito SP for retail, with marketing emphasizing the transit-oriented location, sustainability credentials, and integrated live-work-play neighborhood positioning.

Cambridge Crossing firmographics

Firmographics
Name
Cambridge Crossing
Legal name
DivcoWest Real Estate Services, LLC
Website
https://cambridgecrossing.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Short description
Cambridge Crossing is a 43-acre, 4.5 million SF master-planned mixed-use neighborhood in East Cambridge, MA, developed by DivcoWest, offering life science/tech lab space, multifamily residential (Park 151, 468 units), retail, and 11 acres of open space served by two MBTA stations.
Ownership category
akta.pro rank

Cambridge Crossing industry classification

Industry
Product category
Mixed-Use Real Estate Development
NAICS
New Multifamily Housing Construction (except For-Sale Builders) (236116), Commercial and Institutional Building Construction (236220)
SIC
Real Estate (6500), Land Subdividers & Developers (No Cemeteries) (6552)
akta.pro primary industry
Urban Planning & Master Planning (BPAHAKAD)
akta.pro secondary industry
Retail & Mixed-Use Commercial Construction (IMAFACAB)

Keywords

  • Mixed-use real estate
  • Commercial leasing
  • Residential leasing
  • Life science properties
  • Retail leasing

Where Cambridge Crossing is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Cambridge Crossing business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Infrastructure, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Commercial Life Science Leasing: Leasing of laboratory and office space to life science, biotechnology, and technology companies. Buildings include 250 Water Street (480,000 SF), 222 Jacobs Street (430,000 SF), 350 Water Street (510,000 SF), 450 Water Street (405,000 SF), 441 Morgan Avenue (375,000 SF), and 121 Morgan Avenue (167,300 SF).
  2. Residential Leasing: Leasing of apartment units at Park 151, a 468-unit residential building with market-rate, penthouse, and affordable units.
  3. Retail Leasing: Ground-floor retail and restaurant space leasing throughout the development including The Shed (18,000 SF), 181 Morgan Ave (20,000 SF), and other retail locations.
  4. Amenity and Event Programming: Community events and programming including CX Summer Nights, CX Fit, and CX Movie Nights that drive foot traffic to retail tenants.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels10 records

Cambridge Crossing product offering

Product offering

Core offering

Cambridge Crossing is a 43-acre, 4.5-million-square-foot mixed-use real estate neighborhood in East Cambridge, MA, developed by DivcoWest. The development leases life science and technology commercial buildings, multifamily residential apartments (Park 151), and ground-floor retail/restaurant space to enterprise tenants and individual residents, supported by 11 acres of public open space and seasonal community programming.

Product overview

Cambridge Crossing (CX) is a 43-acre, 4.5-million-square-foot mixed-use destination neighborhood and innovation hub in East Cambridge, MA, developed by DivcoWest. The portfolio comprises life science and technology commercial buildings (including 441 Morgan Avenue, 250 Water Street, 222 Jacobs Street, 350/450 Water Street, 121 Morgan Avenue), multifamily residential buildings (Park 151 with 468 units, 14 North First Street with 120 units), and ground-floor retail spaces (The Shed at 100/110 North First Street, 181 Morgan Avenue, 124-144 Morgan Avenue). CX offers 11 acres of public open spaces and hosts seasonal community programming (CX Summer Nights, CX Fit, CX Movie Nights, CX Cycle Fest). Amenities include the Katherine 'Kittie' Knox Cycle Center, the Brian P. Murphy Memorial Staircase, and the Kith Corner early childhood education center at Park 151. The neighborhood is served by two on-site MBTA stations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cambridge Crossing Mixed-Use Neighborhood A 43-acre, 4.5-million-square-foot mixed-use innovation hub and destination neighborhood in East Cambridge, MA, combining life science and technology commercial space, residential buildings, retail and dining, and 11 acres of public open space.
  • 441 Morgan Avenue Life Science Building A 375,000 SF, 10-story plus two penthouse floors lab-ready life science building targeting LEED Platinum certification. Features five outdoor terraces, direct access to a five-acre park, integrated View Glass smart technology, three underground parking levels, a bike room with showers and lockers, and public art. Currently home to Astellas Pharma.
  • 250 Water Street Life Science Building A 480,000 SF, 9-floor life science building at Cambridge Crossing. Tenants include Bristol Myers Squibb.
  • 222 Jacobs Street Science and Technology Building A 430,000 SF building at Cambridge Crossing housing tenants Philips, AbbVie, Tatte Bakery, and Bon Me.
  • 350 Water Street Science Building A 510,000 SF, 12-floor building at Cambridge Crossing. Primary tenant is Sanofi.
  • 450 Water Street Technology Building A 405,000 SF building at Cambridge Crossing. Tenants include Sanofi and Starbucks.
  • 121 Morgan Avenue Life Science Building A 167,300 SF, 5-floor life science building at Cambridge Crossing.
  • Park 151 Multifamily Residential A 20-story, 468-unit mixed-income residential building at 151 North First Street at Cambridge Crossing, developed in partnership with LCOR. Features include an outdoor pool, fitness center, co-working spaces, indoor/outdoor yoga, sunset terrace, sports simulator, and 19,000 SF of ground-floor retail.
  • 14 North First Street Residential Building A residential building at Cambridge Crossing with 120 units across 8 floors and 18,000 SF of ground-floor retail.
  • The Shed Retail Space (100 & 110 North First Street) An 18,000 SF, two-floor retail building at Cambridge Crossing housing The Lexington, Geppetto, Café Beatrice, and Lamplighter Brewing Co.
  • 181 Morgan Avenue Commercial and Retail Building A 20,000 SF commercial and retail building at Cambridge Crossing. Tenants include REI and DivcoWest.
  • CX Public Open Spaces Eleven acres of public open space at Cambridge Crossing, anchored by The Common at CX (5-acre central green space), and including Maria Baldwin Courtyard, Picnic Grove, William Dawes Field, Amelia Earhart Square, Katherine 'Kittie' Knox Cycle Center, Brian P. Murphy Memorial Staircase, The Dog Run at Child Street Plaza, Lois Lilley Howe Event Plaza, and Pauline Elizabeth Hopkins Lawn.

Quantifiable outcome

  • LEED Platinum certification achieved at 441 Morgan Avenue life science building, reducing potable water use by up to 100% during peak seasons
  • +2 more outcomes

Companies that use Cambridge Crossing

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Cambridge Crossing technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Cambridge Crossing partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered flagship, core and minor.

  • LCORflagshipStrategic or Co-development Partner · 2 May 2022Joint venture partnership between LCOR and DivcoWest for development of Park 151, the 468-unit multifamily residential building at 151 North First Street. LCOR serves as the fully integrated real estate investment, development, and management partner for the residential component.
  • DivcoWestflagshipStrategic or Co-development PartnerDivcoWest, a DivCore Capital Company, is the parent real estate investment and development firm behind Cambridge Crossing. Founded in 1993 and headquartered in San Francisco with offices in multiple cities including Cambridge.
  • Artists For Humanity (AFH)coreStrategic or Co-development PartnerPartnership with Artists For Humanity to create the HERStory art installation celebrating six Cambridge trailblazing women. Teen artists researched and created portraits displayed at The Shed.
  • art_workscoreStrategic or Co-development PartnerArt advisory partnership facilitating public art installations at Cambridge Crossing. Collaborated on Collective Ascension mural project with Community Art Center and the Green Tara 2 installation by Sneha Shrestha.
  • Community Art Center (CAC)coreStrategic or Co-development PartnerCambridge-based organization empowering local youth to use artistic voices. Collaborated with DivcoWest on the Collective Ascension mural project incorporating teen perspectives.
  • East Cambridge Business Association (ECBA)coreGTM or Marketing PartnerPartnership for CX Summer Series events including CX Summer Nights concerts, CX Movie Nights, and community programming. ECBA provides event support and community connections.
  • MBTA (Massachusetts Bay Transportation Authority)flagshipStrategic or Co-development PartnerStrategic partnership to locate the new Lechmere Green Line station and Community College Orange Line station at Cambridge Crossing. DivcoWest supported Green Line Extension (GLX) completion.
  • Astellas PharmacoreChannel Partner/ Reseller/ DistributorMajor tenant occupying two floors (62,000 SF) at 441 Morgan Avenue for Discovery Accelerator incubator and Mitobridge research operations.
  • Ennead ArchitectscoreTechnology or IntegrationArchitectural firm designing 441 Morgan Avenue life science building with views of the Charles River.
  • Jacobs ConsultingcoreTechnology or IntegrationEngineering and consulting partner for 441 Morgan Avenue design and sustainability features including LEED Gold targeting.
  • City of CambridgecoreStrategic or Co-development PartnerPartnership with City of Cambridge for public spaces, HERStory installation at City Hall, and community development initiatives.
  • Kith CornercoreChannel Partner/ Reseller/ DistributorMontessori-inspired early childhood education center at ground level of Park151, accommodating up to 81 children ages 6 weeks to 5 years.
  • Tap 151 Bar and GrillminorChannel Partner/ Reseller/ DistributorTavern-style restaurant at ground level of Park 151 with approximately 6,000 SF, 233 seats, and outdoor seating expected to open 2024.
  • MassBikeminorGTM or Marketing PartnerBicycle advocacy organization partnering on CX Cycle Fest events and promoting cycling infrastructure at Cambridge Crossing.
  • REIcoreChannel Partner/ Reseller/ DistributorOutdoor recreation retail co-op at 181 Morgan Avenue, participating in cycling events and community programming.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Cambridge Crossing competitors and assessment

Company assessment

Direct peers

  • Boston Properties (BXP): Major publicly traded office and life science landlord headquartered in Boston with substantial Cambridge holdings including Kendall Square properties. Directly comparable as a Class A office/lab developer serving similar enterprise tenants in Cambridge.
  • BioMed Realty (Blackstone): Pure-play life science real estate platform owned by Blackstone, with major Cambridge presence and a portfolio of lab/office buildings serving biotech and pharma tenants. Closely comparable in product type and target customer base.
  • IQHQ: Life science real estate developer building purpose-built lab clusters in top-tier innovation markets including San Diego and Boston. Directly comparable as a developer of master-planned life science districts for pharma/biotech tenants.
  • Wexford Science & Technology: Developer and operator of innovation districts and lab/office buildings typically on or adjacent to university campuses. Comparable in lab-ready building development serving university-affiliated life science tenants.
  • Federal Realty Investment Trust: REIT specializing in mixed-use and retail-anchored developments, including Assembly Row in Somerville (adjacent to Cambridge Crossing). Comparable in mixed-use live-work-play format and Greater Boston presence.
  • WS Development: One of the largest privately held mixed-use developers in the U.S., best known for the Boston Seaport master-planned district. Highly comparable as a master developer of mixed-use, transit-oriented neighborhoods in Greater Boston.
  • Alexandria Real Estate Equities: The largest pure-play life science REIT in the U.S. with a major footprint across Cambridge and other top-tier innovation clusters. Directly comparable as a developer, owner, and operator of lab-ready buildings in Cambridge/Kendall Square targeting pharmaceutical and biotech tenants.
  • LCOR: Fully integrated real estate investment, development, and management firm that is the JV partner with DivcoWest on Park 151 at Cambridge Crossing. Direct peer as a multifamily developer-operator within the same project.

Broad incumbents

  • Brookfield Properties: Large diversified real estate developer/operator with major mixed-use master-planned districts (e.g., Manhattan West). Comparable in master-planning scale and mixed-use live-work-play concept, but at much broader national footprint.
  • Tishman Speyer: Major global real estate developer known for master-planned mixed-use districts such as Hudson Yards. Comparable in scale and mixed-use master planning approach, though Cambridge Crossing is at a smaller, more concentrated scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Cambridge Crossing social profiles

Digital presence

Cambridge Crossing compliance and trust

Trust signal

Compliance5 records

Cambridge Crossing financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cambridge Crossing leadership team

Management profile

Number of profiles

Cambridge Crossing subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Cambridge Crossing funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cambridge Crossing M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cambridge Crossing

What does Cambridge Crossing do?

Cambridge Crossing is a 43-acre, 4.5-million-square-foot mixed-use real estate neighborhood in East Cambridge, MA, developed by DivcoWest. The development leases life science and technology commercial buildings, multifamily residential apartments (Park 151), and ground-floor retail/restaurant space to enterprise tenants and individual residents, supported by 11 acres of public open space and seasonal community programming.

Is Cambridge Crossing a public or private company?

Cambridge Crossing is a private company. It is classified as corporate owned and is currently operating.

When was Cambridge Crossing founded?

Cambridge Crossing was founded in 2017. It employs 51 to 100 people.

Where is Cambridge Crossing based?

Cambridge Crossing is headquartered in Cambridge, United States, in the North America region.

How does Cambridge Crossing make money?

Four revenue lines are on record. Commercial Life Science Leasing is the primary driver. The others are residential Leasing, retail Leasing and amenity and Event Programming.

Who are Cambridge Crossing's main competitors?

Direct peers on record are Boston Properties (BXP), BioMed Realty (Blackstone), IQHQ, Wexford Science & Technology, Federal Realty Investment Trust, WS Development, Alexandria Real Estate Equities and LCOR. Broad incumbents are Brookfield Properties and Tishman Speyer.

Does Cambridge Crossing have an API?

No public API is recorded for Cambridge Crossing.

What industry is Cambridge Crossing in?

Cambridge Crossing's product category is Mixed-Use Real Estate Development. Its primary akta.pro industry code is BPAHAKAD, Urban Planning & Master Planning, with a secondary code of IMAFACAB, Retail & Mixed-Use Commercial Construction. Its NAICS code is 236116 and its SIC code is 6500.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales